<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31793258</article-id><article-id pub-id-type="pmc">6894026</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Anesthesia Management for a Patient Undergoing Pulmonary Endarterctomy without Cardiopulmonary Bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1186-0933</contrib-id><name><surname>Saracoglu</surname><given-names>Ayten</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role><role>DESA </role></contrib><contrib contrib-type="author"><name><surname>Ermerak</surname><given-names>Onur</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Sirzai</surname><given-names>Esra Yaman Savci</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Yuksel</surname><given-names>Mustafa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Aykac</surname><given-names>Zuhal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Yildizeli</surname><given-names>Bedrettin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Anesthesiology and Intensive Care, Marmara University Medical School, Istanbul, Turkey.</aff><aff id="aff2">
<label>2</label>Department of Thoracic Surgery, Marmara University Medical School, Istanbul, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Ayten Saracoglu</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-1186-0933">https://orcid.org/0000-0002-1186-0933</ext-link>, Marmara University Medical School - Fevzi Cakmak Mh. Muhsin Yazicioglu Cad. Pendik, Istanbul, Turkey - Zip Code: 34734. E-mail: <email>anesthesiayten@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2019</year></pub-date><volume>34</volume><issue>6</issue><fpage>783</fpage><lpage>787</lpage><history><date date-type="received"><day>19</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Pulmonary endarterectomy is a curative procedure for chronic thromboembolic Pulmonary Hypertension. As usual, cardiopulmonary bypass circuit is required. However, there are several complications attributed to extracorporeal circulation. Hemodilution, systemic inflammatory response syndrome and leukocyte sequestration are circulation related complications. The severe forms include Acute Respiratory Distress Syndrome, Acute Lung Injury, myocardial stunning, dysfunction of the right ventricle, coagulopathy, postoperative stroke or renal dysfunction. In this case report, we aimed to give information about perioperative anesthesia and surgical management of pulmonary endarterectomy which was successfully managed without Cardiopulmonary Bypass. </p></abstract><kwd-group><kwd>Cardiopulmonary Bypass</kwd><kwd>Respiratory Distress Syndrome, Adult, Myocardial Stunning, Hypertension, Pulmonary</kwd><kwd>Endarterecomy, Heart-Lung Machine</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th colspan="2" align="center" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiac output</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PEA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary endarterectomy</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary Bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PEEP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Positive end-expiratory pressure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CTEPH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic thromboembolic pulmonary hypertension</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PHT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary Hypertension</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central Venous Pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PVR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary vascular resistance</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrocardiogram</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Reactive oxygen species</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IBP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Invasive Blood Pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SpO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Oxygen Saturation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NIRS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Near Infrared Spectroscopy</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Total Circulatory Arrest</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary artery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TIVA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Total Intravenous Anaesthesia</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Pulmonary endarterectomy is a curative procedure for chronic thromboembolic pulmonary Hypertension (PHT), with an operative mortality rate of &#x0003c; 5 %<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Mortality may be reduced up to 10 % with an increase in the number of expert centers where more than 20 cases per year are performed<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Because medical treatment is palliative in these group of patients, lung transplantation is the only treatment option for pulmonary endarterectomy. Surgical procedure includes cardiopulmonary bypass (CPB) with sternotomy or lateral thoracotomy<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Deep hypothermic total circulatory arrest (TCA) is widely used<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Thus, during dissections, surgical view can be improved. In this case report, we aimed to give information about perioperative anesthesia and surgical management of pulmonary endarterectomy which was successfully managed without CPB. </p></sec><sec sec-type="cases"><title>CASE REPORT</title><p>A 64-year-old male with shortness of breath (New York Heart Association Class III), and elevation of right diaphragm and chronic thromboembolic pulmonary hypertension (CTEPH) for 1-year period was referred for pulmonary endarterectomy (PEA) and diaphragmatic plication. The demographics and the preoperative evaluation results are summarized in <xref rid="t1" ref-type="table">Table 1</xref>. His medical history revealed that 8years ago the patient underwent PEA for CTEPH by our team and lumber discectomy 10 years ago. He was under warfarine and inhaled bronchodilators medication. His echocardiogram revealed normal left ventricular function with an ejection fraction of 63% but a dilated right ventricle with moderate tricuspid regurgitation. A right heart catheterization revealed slightly elevated pulmonary artery (PA) pressure of 41,4/14 mm Hg (mean, 26 mm Hg) and cardiac output (CO) of 2.9 L/min and TAPSE &#x0003e;15mm. Pulmonary vascular resistance (PVR) was calculated as 386 dynes/s/cm<sup>&#x02212;5</sup>. Computed tomographic pulmonary angiography of his chest showed complete obstruction in his pulmonary vasculature on the right lower lobe consistent with chronic thromboembolic disease and elevation of right diaphragm (<xref ref-type="fig" rid="f1">Figure 1</xref>). Ventilation perfusion scanning confirmed the diagnosis of CTEPH. Pulmonary endarterectomy is routinely performed under general anaesthesia through a median sternotomy and using extracorporeal circulation<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. However, since our patient had previous history of PEA surgery, <italic>i.e</italic>. previous sternotomy and only right lower lobe disease, unilateral PEA and diaphragmatic plication was performed by right thoracotomy without cardiopulmonary bypass (CPB). </p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The demographics and the preoperative evaluation results.</p></caption><table frame="hsides" rules="rows"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Demographics</th><th align="center" rowspan="1" colspan="1">Male, 64 years old, 72 kg</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Comorbidity</td><td align="center" rowspan="1" colspan="1">Chronic Obstructive Pulmonary Disease with the requirement of home BIPAP</td></tr><tr><td align="left" rowspan="1" colspan="1">History</td><td align="center" rowspan="1" colspan="1">Lumber discectomy 10 years ago, Pulmonary Endartrectomy 8 years ago,</td></tr><tr><td align="left" rowspan="1" colspan="1">Drugs</td><td align="center" rowspan="1" colspan="1">Warfarine and inhaled bronchodilators</td></tr><tr><td align="left" rowspan="1" colspan="1">Echocardiography</td><td align="center" rowspan="1" colspan="1">Ejection Fraction: 63 %<break/> Mitral and Tricuspid Valve Regurgitation: +1<break/> Sclerotic Aortic Valve<break/> Left Atrial diameter: 44 mm<break/> TAPSE: &#x0003e;15 mm<break/> sPAP: 41,4 mmHg<break/> Left Ventricular Hypertrophy<break/> Left ventricular diastolic dysfunction</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative examination</td><td align="center" rowspan="1" colspan="1">Mallampati II<break/> ASA II<break/> New York Heart Association (NYHA) III/IV<break/> Glasgow Coma Scale:15<break/> Breathlessness on moderate physical exertion<break/> The lung sounds normal<break/> 6-min walk test:</td></tr><tr><td align="left" rowspan="1" colspan="1">ECG</td><td align="center" rowspan="1" colspan="1">Sinus rhythm</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood count</td><td align="center" rowspan="1" colspan="1">Hematocrit: 48.2 %<break/> Hemoglobin: 16.4 g/dL<break/> White Blood Cell: 5300/mL<break/> Platelet: 339 X 109</td></tr><tr><td align="left" rowspan="1" colspan="1">Coagulation prophile</td><td align="center" rowspan="1" colspan="1">INR: 1.12<break/> PT: 12.4 s<break/> aPTT: 33.7 s</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood gase</td><td align="center" rowspan="1" colspan="1">Ph: 7.44<break/> PCO2: 37.9<break/> PO2: 68.1<break/> SpO2: 96.2<break/> HCO3: 26.4<break/> BE: 2.3<break/> Lac: 1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Electrolytes</td><td align="center" rowspan="1" colspan="1">K: 4.3<break/> Na: 129<break/> Ca: 4.36<break/> Cl: 113</td></tr></tbody></table></table-wrap><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>(A). CT scan showing complete thromboembolic obstruction of the right lower lobe and (B). Elevation of the right diaphragm.</p></caption><graphic xlink:href="rbccv-34-06-0783-g01"/></fig>
</p><p>Following informed patient&#x02019;s consent, the patient was monitorized using Electrocardiogram (ECG), invasive blood pressure (IBP), oxygen saturation (SpO<sub>2</sub>), central venous pressure (CVP), Near Infrared Spectroscopy (NIRS) and urine output. During the induction of anesthesia a bolus dose of propofol 2.5 mg/kg and remifentanil 0.1 mcg/kg were administered intravenously. Anesthesia was maintained with propofol 6 mg/kg/h, fentanyl 2 mcg/kg/h, 60% O<sub>2</sub> and 40% air. Pressure controled ventilation was used with a Pinsp:19 mmHg, Resiratory Rate of 14/min, inspiration:expiration ratio of 1:2 and a Ppeak of 21 mmHg.</p><p>There was not any complication during the induction of anesthesia. A left double lumen tube was inserted. No bleeding occured during the initial thoracotomy. No vasopressor or inotropic agent were used during the procedure. Nitroglyserine infusion was given with inhaled Nitric Oxide. </p><p>Following right thoracotomy, right main pulmonary artery (PA) and both superior and inferior pulmonary veins are clamped. Arteriotomy was performed in the intralobar artery of the right PA and the endarterectomy specimen was circumferentially followed down to the segmental and subsegmental branches of the right lower lobe (<xref ref-type="fig" rid="f2">Figure 2</xref>). Plication of the right diaphragm was performed following PEA.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Surgical specimen of pulmonary endarterectomy.</p></caption><graphic xlink:href="rbccv-34-06-0783-g02"/></fig>
</p><p>The total duration for one lung ventilation was 120 min. Total cross-clamp time of pulmonary artery was 25 min. Initially, there was a bleeding amount of 800 cc. During the procedure bleeding reached to 1100 cc. Afterwards 300 ml of blood filtered through cell saver given back to the patient.</p><p>At the end of surgery, total duration of one lung ventilation was 6 hours. The arterial blood gas analysis showed a Ph of 7.33 with PCO<sub>2</sub>: 42.9 mmHg, PO<sub>2</sub>: 230 mmHg, SpO<sub>2</sub>: 99,6% and a BE of - 2.8. Heart rate was 78 beats/min IBP: 99/64 mmHg and the CVP was 5 mmHg. Total amount of urine output was 1500 cc and the total bleeding was 1200 cc. The amount of balanced Electrolyte Solution was 1000 cc, Colloid (Gelofusine) was 1500 cc, the Cell Saver Blood was 300 cc. Patient was transferred to the ICU postoperatively. In the ICU, Ph was 7.32, PCO<sub>2</sub>: 42 mmHg, PO<sub>2</sub>: 143 mmHg, SpO<sub>2</sub>: 99%, HCO<sub>3</sub>: 21, BE: -4.4 with the electrolytes of K: 5.8 mEq/L, Na: 135 mEq/L, Lactate: 1.3, Ca: 4.5 mEq/L, Cl: 115 mEq/L. The glucose level was 189 mg/dL with the Hb value of 14.5 g/dL and a Htc level of 45%. The patient was extubated on the 4<sup>th</sup> postoperative day. The patient stayed in intensive care unit for 10 days. He was discharged after a 10-day follow-up period.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Patient who underwent pulmonary endarterectomy due to bilateral pulmonary thromboembolism, was reoperated for right pulmonary artery lesion and was successfully managed without CPB procedure. Ever since our PEA program was started with acceptable results<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>, more than 500 operations have been performed over seven years (80 cases last year), with increased institutional and surgical experience resulting in our center becoming the only expert PEA center in Turkey. However, this is our first case who was operated on through right thoracotomy and without CPB.</p><p>The use of Total Intravenous Anaesthesia (TIVA), pressure controlled mechanical ventilation, and restricted fluid regimen were the pearls of successful anesthesia management.</p><p>Since deep hypothermic circulatory arrest was not applied, cerebral protection was not needed by administering mannitol, methyl prednisolone, phenytoin Na and thiopental for cerebral protection. In addition, the process of rewarming patients after TCA is also very important. Rapid heating can lead to systemic air embolisms or cerebral oxygen desaturation. Therefore, 90 to 120 minutes is required to reach a temperature of about 36.5 &#x000b0;C<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Due to the long aortic cross clamp time and the long hypothermic period, it may also be difficult to wean from CPB. Inotropic support may be needed during this period. Since CPB was not applied in our patient, the use of inotropic agent was not required. In addition, severe reperfusion injury may develop during weaning. This complication can occur especially in patients with right heart failure with diffuse blood clots in pulmonary artery<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. During thoracotomy, one lung ventilation was applied. It has been shown that accumulation of reactive oxygen species (ROS) occur during one lung ventilation causing oxidative stress. These changes can be reduced by propofol<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. In addition, propofol reduces both the amount and the duration of ROS formation in circulation. Considering these results, TIVA was preferred in our case with continuous infusion of fentanyl and propofol. Morever, unlike inhalation agents, it does not inhibit hypoxic pulmonary vasoconstriction. On the other hand, in a multicenter randomized controlled study involving 100 patients, sevoflurane and TIVA were compared; no significant difference between the two groups were found in terms of prolonged ICU stay, death, 30-day or 1-year mortality<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. During thoracic surgery, one lung ventilation causes the emergence of an inflammatory response in the bronchial epithelium. Inflammatory cytokines such as TNF a, IL-1b, IL-6 , IL-8 are important chemoattractants affecting the recruitment of alveolar macrophages and neutrophils<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. They also lead to inflammatory response inducing coagulation. Besides in our previous experimental study, we found that propofol caused less neutrophil infiltration in lungs, reduced free-radical-mediated lipid peroxidation and resulted in amelioration of systemic inflammation<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. This was another reason why TIVA was preferred for this patient.</p><p>Furthermore, the ventilation strategy that we used intraoperatively is an important parameter that determines survival in patients. In this patient with high pulmonary artery pressure, protective lung ventilation was applied to prevent barotrauma with the use of pressure-controlled ventilator mode including the use of positive end-expiratory pressure (PEEP) and stepwise alveolar recruitment manoeuvres. Right heart performance was very susceptible being affected by positive pressure ventilation<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Thus, we also avoided to cause increased right heart pressure and right-ventricular afterload. With the use of cell salvage, unnecessary transfusion has been avoided. </p><p>The patient underwent bilateral pulmonary endarterectomy eight years ago. This time the patient with a lesion in the right pulmonary artery did not enter the CPB because of unilateral surgery. In this rare redo case, restrictive fluid therapy was given (<xref rid="t1" ref-type="table">Table 1</xref>). Vasodilatation was caused by nitric oxide infusion, resulted in optimized perfusion in pulmonary vasculature during surgical procedure.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In the reported case, we have demonstrated that optimizing hemodynamic management through goal directed use of blood products and preventing hypoperfusion reduces not only bleeding but also using unnecessary vasopressors and blood products during off- pump pulmonary endarterectomy. </p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">OE</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EYSS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MY</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">ZA</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">BY</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Marmara University Medical School - Anesthesiology and Intensive Care, Fevzi Cakmak Mh. Muhsin Yazicioglu Cd. Pendik Istanbul, Turkey.</p></fn><fn fn-type="financial-disclosure"><p><bold>No financial support.</bold></p></fn><fn fn-type="COI-statement"><p><bold>No conflict of interest.</bold></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McRae</surname><given-names>K</given-names></name><name><surname>Shargall</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Thenganatt</surname><given-names>J</given-names></name><name><surname>Slinger</surname><given-names>P</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Feasibility of blood conservation strategies in pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2011</year><volume>13</volume><issue>1</issue><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1510/icvts.2010.252767</pub-id><pub-id pub-id-type="pmid">21422156</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>D</given-names></name><name><surname>Madani</surname><given-names>M</given-names></name><name><surname>Fadel</surname><given-names>E</given-names></name><name><surname>D&#x02019;Armini</surname><given-names>AM</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name></person-group><article-title>Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension</article-title><source>Eur Respir Rev</source><year>2017</year><volume>26</volume><issue>143</issue><fpage>160111</fpage><lpage>160111</lpage><pub-id pub-id-type="doi">10.1183/16000617.0111-2016</pub-id><pub-id pub-id-type="pmid">28298388</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Delcroix</surname><given-names>M</given-names></name><name><surname>Jenkins</surname><given-names>DP</given-names></name><name><surname>Channick</surname><given-names>R</given-names></name><name><surname>Dartevelle</surname><given-names>P</given-names></name><name><surname>Jansa</surname><given-names>P</given-names></name><etal/></person-group><article-title>Chronic thromboembolic pulmonary hypertension</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>25 Suppl</issue><fpage>D92</fpage><lpage>D99</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2013.10.024</pub-id><pub-id pub-id-type="pmid">24355646</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedullo</surname><given-names>P</given-names></name><name><surname>Kerr</surname><given-names>KM</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Auger</surname><given-names>WR</given-names></name></person-group><article-title>Chronic thromboembolic pulmonary hypertension</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>183</volume><issue>12</issue><fpage>1605</fpage><lpage>1613</lpage><pub-id pub-id-type="doi">10.1164/rccm.201011-1854CI</pub-id><pub-id pub-id-type="pmid">21330453</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildizeli</surname><given-names>B</given-names></name><name><surname>Tas</surname><given-names>S</given-names></name><name><surname>Yanartas</surname><given-names>M</given-names></name><name><surname>Kaymaz</surname><given-names>C</given-names></name><name><surname>Mutlu</surname><given-names>B</given-names></name><name><surname>Karakurt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension: an institutional experience</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>44</volume><issue>3</issue><fpage>e219</fpage><lpage>e227</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezt293</pub-id><pub-id pub-id-type="pmid">23729746</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manecke</surname><given-names>GR</given-names></name></person-group><article-title>Anesthesia for pulmonary endarterectomy</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2006</year><volume>18</volume><issue>3</issue><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1053/j.semtcvs.2006.09.005</pub-id><pub-id pub-id-type="pmid">17185186</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellers</surname><given-names>D</given-names></name><name><surname>Perrot</surname><given-names>M</given-names></name><name><surname>McRae</surname><given-names>K</given-names></name><name><surname>Slinger</surname><given-names>P</given-names></name></person-group><article-title>Anesthesia for pulmonary endarterectomy and extracorporeal membrane oxygenation in a patient with achondroplasia</article-title><source>J Cardiothorac Vasc Anesth</source><year>2017</year><volume>31</volume><issue>5</issue><fpage>1789</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2017.02.038</pub-id><pub-id pub-id-type="pmid">28502457</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>YP</given-names></name><name><surname>Wu</surname><given-names>PY</given-names></name><name><surname>Chien</surname><given-names>CT</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name></person-group><article-title>Propofol infusion shortens and attenuates oxidative stress during one lung ventilation</article-title><source>Acta Anaesthesiol Taiwan</source><year>2008</year><volume>46</volume><issue>4</issue><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/S1875-4597(09)60003-5</pub-id><pub-id pub-id-type="pmid">19097962</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landoni</surname><given-names>G</given-names></name><name><surname>Guarracino</surname><given-names>F</given-names></name><name><surname>Cariello</surname><given-names>C</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Baldassarri</surname><given-names>R</given-names></name><name><surname>Borghi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Volatile compared with total intravenous anaesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study</article-title><source>Br J Anaesth</source><year>2014</year><volume>113</volume><issue>6</issue><fpage>955</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1093/bja/aeu290</pub-id><pub-id pub-id-type="pmid">25186820</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugasawa</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Kumakura</surname><given-names>S</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Kugimiya</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><etal/></person-group><article-title>The effect of one-lung ventilation upon pulmonary inflammatory responses during lung resection</article-title><source>J Anesth</source><year>2011</year><volume>25</volume><issue>2</issue><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1007/s00540-011-1100-0</pub-id><pub-id pub-id-type="pmid">21301891</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celik</surname><given-names>MG</given-names></name><name><surname>Saracoglu</surname><given-names>A</given-names></name><name><surname>Saracoglu</surname><given-names>T</given-names></name><name><surname>Kursad</surname><given-names>H</given-names></name><name><surname>Dostbil</surname><given-names>A</given-names></name><name><surname>Aksoy</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of propofol and midazolam on the inflammation of lungs after intravenous endotoxin administration in rats</article-title><source>Eurasian J Med</source><year>2015</year><volume>47</volume><issue>2</issue><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.5152/eajm.2014.70</pub-id><pub-id pub-id-type="pmid">26180495</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paternot</surname><given-names>A</given-names></name><name><surname>Repess&#x000e9;</surname><given-names>X</given-names></name><name><surname>Vieillard-Baron</surname><given-names>A</given-names></name></person-group><article-title>Rationale and description of right ventricle-protective ventilation in ARDS</article-title><source>Respir Care</source><year>2016</year><volume>61</volume><issue>10</issue><fpage>1391</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.4187/respcare.04943</pub-id><pub-id pub-id-type="pmid">27484108</pub-id></element-citation></ref></ref-list></back></article>